Patent Assignment
Reel/Frame 024780/0680
Change of Name
Recorded: 2010-08-03
Pages: 8
Assignor
IDEC PHARMACEUTICALS CORPORATION
Executed: 2003-11-12
Assignee
BIOGEN IDEC INC.
133 BOSTON POST ROAD, WESTON, MASSACHUSETTS, 02493
Covered Properties
(4)
New Clinical Parameters for Determining Hematologic Toxicity Prior to Radioimmunotheraphy
Patent:
6,451,284 →
Application:
09/625,856 →
New Clinical Parameters for Deteriming Hematologic Toxicity Prior to Radioimmunotherapy
Clinical Parameters for Determining Hematologic Toxicity Prior to Radioimmunotherapy
Application:
11/679,687 →
Publication:
US 2007/0148714
New Clinical Parameters for Determining Hematologic Toxicity Prior to Radioimmunotherapy
Application:
60/148,288 →
Related Assignments
(4)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Jul 17, 2002
From: RAESTETTER, WILLIAM; WHITE, CHRISTINE A.
To: IDEC PHARMACEUTICALS CORPORATION
Reel/Frame 013095/0931 →
Change of Name
Aug 6, 2004
From: IDEC PHARMACEUTICALS CORPORATION
To: BIOGEN IDEC INC.
Reel/Frame 015044/0873 →
Assignment of Assignor's Interest
Jun 22, 2010
From: RAESTETTER, WILLIAM; WHITE, CHRISTINE A.
To: IDEC PHARMACEUTICALS CORPORATION
Reel/Frame 024575/0346 →
Change of Name
Apr 30, 2015
From: BIOGEN IDEC INC.
To: BIOGEN INC.
Reel/Frame 035552/0202 →